Form 4 for EW Edwards Lifesciences
Accepted 2022-07-11 00:00:00 ET · period of report 2022-07-07 · accession 0001225208-22-008764 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-11 | 2022-07-07 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | A - Grant | $0.00 | +6,100 | 168.9K | +4% | $0 |
| DM | 2022-07-11 | 2022-07-07 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | A - Grant | $0.00 | +62.1K | 7,625 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-07 | A | A | 6,100 | $0.00 | 168,874.87 | D | — | — | (F1) These restricted stock units were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 2 | Derivative | Employee Stock Option (Right to Acquire) | 2022-07-07 | A | A | 54,500 | $0.00 | 54,500 | D | $98.43 · 2023-07-07 to 2029-07-06 | 54,500 Common Stock | (F2) These options were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. |
| 3 | Derivative | Performance Rights | 2022-07-07 | A | A | 7,625 | $0.00 | 7,625 | D | — · 2025-07-07 to — | 7,625 Common Stock | (F3) Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |